PLD1 and cancer: Additionally, PLD1/2 has been reported to regulate several growth-related signaling pathways through its lipid product PA such as the mammalian target of rapamycin (mTOR) (18) and the Hippo pathway (19), highlighting their crucial roles in growth control and cancer development.